{
  "reasoning": "The query focuses on the interaction between PPARs and RXRs, specifically regarding the inhibitory effects of PPAR ligands. While existing results provide a good foundation on PPAR function, they lack direct information on this specific inhibition mechanism. To address this gap, we need expertise from multiple disciplines: pharmacology to understand ligand interactions, molecular biology to delve into receptor mechanisms, and potentially endocrinology to explore hormonal influences.",
  "selected_experts": [
    "Pharmacologist",
    "Molecular Biologist",
    "Endocrinologist",
    "Biochemist",
    "Toxicologist"
  ],
  "expert_insights": [
    "PPAR ligands can indeed inhibit PPAR-RXR heterodimers, but the mechanism is complex and depends on the specific ligand. Some ligands might directly block binding to the RXR site, while others may induce conformational changes in the PPAR subunit that hinder RXR interaction.",
    "At a molecular level, PPAR-RXR heterodimerization requires specific amino acid residues for receptor interaction and DNA binding. Ligand binding to PPAR can disrupt these interactions by altering the receptor conformation or interfering with dimerization domains.",
    "Hormonal pathways can influence PPAR-RXR activity.  For example, thyroid hormone receptors can compete with RXRs for heterodimerization with other nuclear receptors, potentially impacting PPAR function.",
    "Investigating potential enzyme-mediated metabolism of PPAR ligands is crucial.  Metabolic breakdown products might exhibit different binding affinities and inhibitory effects compared to the parent compound.",
    "Understanding the toxicological profile of PPAR ligands is essential, as they could exert unintended effects on other receptors or signaling pathways."
  ],
  "cross_connections": [
    "Hormonal regulation",
    "Ligand-receptor interactions",
    "Nuclear receptor signaling",
    "Enzyme metabolism",
    "Toxicology"
  ],
  "recommended_resources": [
    "Current Protocols in Molecular Biology: Chapter 17, Receptor Interactions",
    "Endocrinology and Metabolism Clinics of North America:  Focus on Nuclear Receptors",
    "Reviews in Endocrinology & Metabolism: Articles on PPAR Ligand Pharmacology",
    "Toxicological Sciences: Studies on PPAR Ligand Toxicity",
    "Structure-Activity Relationships database for ligand binding to nuclear receptors"
  ],
  "extracted_terms": [
    "PPAR",
    "RXR",
    "Heterodimerization",
    "Ligand Binding",
    "Conformational Change",
    "Transcriptional Regulation",
    "Endocrine Signaling",
    "Nuclear Receptor",
    "Toxicology"
  ],
  "augmented_query": "Influence of PPAR ligands on PPAR-RXR heterodimerization and transcriptional activity; exploring  mechanisms of inhibition, hormonal modulation, and toxicological implications.",
  "ndcg": {
    "NDCG@10": 0.63093,
    "NDCG@100": 0.63093,
    "NDCG@1000": 0.63093,
    "NDCG@10000": 0.63093
  },
  "map": {
    "MAP@10": 0.5,
    "MAP@100": 0.5,
    "MAP@1000": 0.5,
    "MAP@10000": 0.5
  },
  "recall": {
    "Recall@10": 1.0,
    "Recall@100": 1.0,
    "Recall@1000": 1.0,
    "Recall@10000": 1.0
  },
  "precision": {
    "P@10": 0.1,
    "P@100": 0.01,
    "P@1000": 0.001,
    "P@10000": 0.0001
  },
  "delta": 0.53644,
  "instruction": "expert",
  "query": "PPAR-RXRs are inhibited by PPAR ligands.",
  "query_id": "913",
  "dataset": "scifact",
  "generator_model": "ollama_chat/gemma2:9b-instruct-q8_0",
  "temperature": 1.0,
  "thought_process": "Looking at the query \"PPAR-RXRs are inhibited by PPAR ligands,\" this makes me think of the complex interactions between these nuclear receptors and how ligands can affect their activity. Though the user might actually be trying to understand the specific mechanisms of inhibition, I notice the query lacks direct information on this process. It seems we need to delve into the realms of pharmacology to understand ligand interactions, molecular biology to explore receptor mechanisms, and potentially endocrinology to consider hormonal influences.\n\nAs I begin to approach this query, I realize that applying the \"Query Expansion via Multi-Disciplinary Expert Panel\" technique could provide a comprehensive understanding. This technique involves convening a panel of experts from diverse disciplines to analyze the query, each contributing their specialized knowledge, terminology, and perspectives. By doing so, we can systematically identify key concepts, methodologies, and specialized vocabulary from multiple angles.\n\nLet's start with the expert selection process. We have a pharmacologist, a molecular biologist, an endocrinologist, a biochemist, and a toxicologist on board. Each of these experts will analyze the query from their disciplinary perspective, noting what the original query might be overlooking from their expertise. The pharmacologist might focus on the ligand interactions and how they inhibit PPAR-RXRs, while the molecular biologist could delve into the specifics of receptor mechanisms and how ligands affect these processes. The endocrinologist would consider how hormonal pathways influence PPAR-RXR activity, and the biochemist could explore the metabolic aspects of PPAR ligands. Lastly, the toxicologist would examine the potential unintended effects of these ligands on other receptors or signaling pathways.\n\nAs each expert contributes their insights, we begin to see cross-disciplinary connections emerge. For instance, the concept of ligand-receptor interactions is crucial in both pharmacology and molecular biology, while hormonal regulation connects endocrinology with molecular biology. The biochemist's perspective on enzyme-mediated metabolism of PPAR ligands intersects with toxicology, highlighting the importance of understanding the metabolic breakdown products of these ligands.\n\nDuring the panel discussion, these experts debate different approaches to the query, highlighting complementary tools and frameworks from their disciplines. They clarify terminology differences between fields, ensuring a unified understanding of key concepts like heterodimerization, conformational change, and transcriptional regulation.\n\nEach expert then provides recommended resources and domain-specific search terms. The pharmacologist suggests articles on PPAR ligand pharmacology, while the molecular biologist recommends protocols on receptor interactions. The endocrinologist points towards reviews on nuclear receptors, and the biochemist advises on databases for structure-activity relationships of ligand binding to nuclear receptors. The toxicologist recommends studies on PPAR ligand toxicity.\n\nAs we compile and synthesize the insights from all experts, we identify terms with cross-disciplinary relevance, such as PPAR, RXR, heterodimerization, ligand binding, and toxicology. We prioritize terms that add new dimensions to the search, like hormonal modulation and enzyme metabolism, which emerge from the intersection of different disciplines.\n\nThrough this process of applying the \"Query Expansion via Multi-Disciplinary Expert Panel\" technique and exploring related threads, I believe the expanded query should capture the influence of PPAR ligands on PPAR-RXR heterodimerization and transcriptional activity, exploring mechanisms of inhibition, hormonal modulation, and toxicological implications. This approach not only enriches our understanding of the original query but also demonstrates how structured techniques, combined with natural cognitive patterns and expert insights, can lead to a more comprehensive and nuanced exploration of complex topics.",
  "though_generator": "openrouter/meta-llama/llama-3.3-70b-instruct"
}